Cabot Prime Pro Week Ending November 13, 2020
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any changes to our recommendations over the previous week. We include this table at the bottom of the Weekly Summary, and provide a link here at the top to the Stock Recommendations Tracker.
Cabot Weekly Review (Video)
In this week’s stock market video, Mike Cintolo discusses the wild action among the market and growth stocks. Overall, he’s optimistic and thinks the market will have a good run in the months ahead, but the trick is near-term timing given the crosscurrents, volatility and rotation. Bottom line, the next few days will be key, and if things go well, there should be a lot of leaders to sink your teeth into.
UPCOMING CABOT EVENTS:
Software Stocks Today: Buy, Sell, or Hold? with Tyler Laundon
FREE WEBINAR: Thursday, November 19 Sign up now.
Cabot Retirement Club Member Call - November 2020
FREE WEBINAR FOR PRIME MEMBERS ONLY: December 1, 2020 Sign up now.
Cabot Micro-Cap Insider Member Call – December 2020
FREE WEBINAR FOR PRIME PRO MEMBERS ONLY: Thursday, December 10 Sign up now.
Advisory Services
Cabot Growth Investor
Bi-weekly Update November 12: Stay cautious for now as we wait to see whether growth stocks can find their footing (which they’ve done for a couple days in a row now). The overall market looks good, and after taking partial profits in Pinterest (PINS) and cutting our loss in Datadog (DDOG) this week, our cash position is well over 50%, which is likely too high. However, given the action, we’d like to see a couple more days of stabilization before putting money back to work. Mike has no new changes tonight.
Special Bulletin November 11: Though we gave it every chance to hold up, Datadog (DDOG) is taking on more water after earnings last night. We’re forced to cut our loss today, which will leave us with north of 50% on the sideline. Sell Datadog (DDOG).
Special Bulletin November 10: Growth stocks have taken a beating so far this week as a sharp rotation is underway. Given that the Model Portfolio was 41% cash coming into this week, we’re not craving more cash, but we are making one small move tonight—selling one-third of our position in Pinterest, booking partial profits—and keeping some relatively tight stops on a couple of others. Sell 1/3 shares in Pinterest (PINS).
Bi-weekly Issue November 5: Hold your strong performers and be selective on new buys as we see if this pop is the Real McCoy. In the Model Portfolio, we cut loose our weakest performers during the October slide, but tonight, we’ll add a half-sized position in NovoCure (NVCR), bringing our cash position down to around 41%, while aiming for some new buys in the days ahead depending on the evidence.
Other Stocks of Interest November 5: Follow ups to stocks featured July 2, 2020 (issue 1449) to November 5, 2020 (issue 1458). Since many of the stocks written about in Other Stocks of Interest don’t make their way into the Model Portfolio, you won’t see them followed on a regular basis in the issues. However, we are monitoring these stocks, and this listing gives you a quick view of our latest thoughts.
Cabot Top Ten Trader
Movers & Shakers November 13: The last three weeks have been as whippy as we can remember, with a huge selloff three weeks ago, a buoyant rally last week, and then a rotation (and, to some extent, a re-rotation) all within the past few trading days. As of Friday morning, the big-cap indexes are mixed, while small- and mid-cap indexes are up 2% to 4%. Mike’s Buy ideas today are: Axon Enterprise (AAXN), Shift4 Payments (FOUR), Uber (UBER). Mike suggests Sells for Datadog (DDOG) and Sea Ltd. (SE)
Weekly Issue November 9: Overall, the evidence has clearly improved so we’re optimistic the next leg up has begun, but at the same time, it’s likely the crosscurrents we’re seeing among individual names and sectors will be with us a while (rotation and re-rotation, etc.). Thus, we’re OK with gradually extending your line, but it’s probably not going to be like April or May when throwing a dart made you money; continue to pick your spots and stocks carefully and give names room to maneuver. This week’s list is growth-heavy after we saw many positive earnings reactions last week; yes, most took on some water today but they remain in uptrends until proven otherwise. Our Top Pick is Zendesk (ZEN), which is early stage and acts like it wants to go higher. Try to buy on weakness.
Cabot Options Trader and Cabot Options Trader Pro
Note that the current week’s Weekly Update, earnings updates, position updates and stocks on watch are posted on the website in the Market Update section, which is deleted each week.
Cabot Options Trader Position Update November 13: Jacob’s Taiwan Semiconductor (TSM) position is coming alive as the stock is trading higher by 4%, and at a new high above 93. Jacob also gives an earnings breakdown for people holding onto JD.com (JD) position.
Cabot Options Trader Basic and Pro Mental Stops November 11: The market is in a very interesting spot as old school cyclicals have been flying higher (GM), while growth stocks have been under pressure. However, there is also the potential for this rotation to violently swing back to growth in favor, and cyclicals back to the trash heap. Jacob will simply let the situation play itself out, today he will add some mental stops to our big winners and positions that are on the clock as they approach expiration.
Cabot Options Trader Pro Trade Alert November 10: Sell your JD.com (JD) November 62.5/85 Bull Call Spread for $14.50 or more.
Cabot Options Trader Basic Trade Alert November 10: Sell your JD.com (JD) November 62.5 Calls for $15 or more.
Cabot Options Trader Position Update November 9: Now that the market is open, let’s VERY quickly dive in on our stocks that are making the biggest moves following this morning’s positive Covid vaccine update from Pfizer (PFE).
Cabot Options Trader Pro Weekly Update November 9: Jacob has 10 Long positions: GM, JD, MSFT, NET, UBER, QCOM, SNAP, TSM, XLF, ZNGA and short position: QQQ December Puts.
Cabot Options Trader Basic Weekly Update November 9: The Chicago Board of Options Exchange Volatility Index (VIX) closed the week lower by 35%, at 25. Jacob can’t imagine a scenario where the VIX drops below 20 until there is total resolution to the election drama (this morning’s COVID-19 vaccine breakthrough may test the 20 level).
Cabot Undervalued Stocks Advisor
Weekly Update November 11: Just like that, the stock market emerged from its dark mood of October 30th to surge 8.6% in six trading days, with reinvigorated optimism following the evaporation of the election cloud and news of a very promising Covid vaccine. This week Bruce added a new Buy recommendation for Coca-Cola (KO).
Special Bulletin November 9: We are moving MKS Instruments (MKSI), Voya (VOYA) and TOTAL (TOT) to a Sell.
Monthly Issue November 4: This past week at least modestly illustrated the merits of a value strategy. Two of our three “Strong Buy” stocks, Molson Coors Beverage Company and Equitable Holdings, surged on company-specific news that highlighted their underlying value. Other “non-value” stocks not on our recommended list, like Apple, Amazon, Microsoft and Facebook, provided company-specific news that should have been flattering but instead sent their stocks down between 5% and 9%. For investors that focus on high-growth and momentum-driven stocks, having at least a few value stocks can provide portfolio stability. This added stability can help boost investor resolve to stay the course when markets get sloppy and the macro news looks grim, as it did late last week. Bruce has two portfolio changes today: Columbia Sportswear (COLM) and Marathon Petroleum (MPC) both move from Hold to Buy.
Cabot Stock of the Week
Weekly Issue November 9: The news that Pfizer has a promising Covid vaccine, combined with the weekend news that Biden/Harris won the presidential election, triggered a wave of buying (and selling) on Wall Street this morning, rewarding both large caps and small caps while penalizing (at least temporarily) stocks that had benefited from the COVID shutdown. Coming on top of last week’s strength on the realization that Congress would remain divided, this action is enough to turn our intermediate-term market timing indicator back to the positive side again, and thus I recommend that you be heavily invested in stocks with great growth potential, like this week’s featured stock, NovoCure (NVCR). It was originally recommended by Mike Cintolo in Cabot Top Ten Trader. Tim has one portfolio change today: Columbia Sportswear (COLM) to Buy.
Cabot Global Stocks Explorer
Bi-weekly Issue November 12: Election results seem clear and will have a mixed impact on investor appetites. While still up in the air due to a pair of Georgia run-off elections, it seems likely that the GOP will control the U.S. Senate and thus be able to block any significant tax increases. Today, Carl’s new recommendation, Fortress Value Acquisition Corporation (FVAC), is a special purpose acquisition company (SPAC) that is merging into MP Partners to become MP Materials. The company owns and operates one of the world’s largest integrated rare earth mining and processing facilities in Mountain Pass, CA.. There is one portfolio change today: VanEck Rare Earth/Strategic Metals ETF (REMX) moves from Buy a Half to Sell.
Bi-weekly Update November 5: It appears that we will have a sharply divided government in Washington, which Wall Street initially is taking as a positive. A better way of putting it is that it could have been much worse for investors. From time to time, Carl is going to give you a more extensive update on a recommended stock in the Explorer portfolio. This week, NovoCure (NVCR), which has almost doubled in the last six months, is center stage. There are no portfolio changes today.
Cabot Small-Cap Confidential
Weekly Update November 12: The market is working its way through significant developments on many fronts – U.S. presidential race, raging pandemic, positive vaccine developments – and information overload is causing some intense action in individual stocks. The pendulum has been swinging wildly as investors have dumped growth and bought value, then somewhat reversed that trend. It should start to settle down and find a rhythm soon. Tyler has recent portfolio changes for: Sprout Social (SPT) and Karyopharm Therapeutics (KPTI) as both move to a BUY
Special Bulletin November 11: Palomar (PLMR) reported Q3 results that missed expectations yesterday. Revenue was up 48% to $45 million while net loss was $15.7 million because of the hurricane-related catastrophe losses. Stripping those out, adjusted net income was $13.7 million, versus $9.6 million a year ago. Aside from the hurricane-related losses (obviously something we can’t ignore) the quarter was good. Tyler continues to advise a BUY for Palomar (PLMR).
Special Bulletin November 10: Sprout Social (SPT) is a rare bright spot in software today, as the company’s Q3 report yesterday has shined a light on this little company’s potential once again. Revenue in the quarter of $33.7 million was up 27% and beat by $700K while adjusted EPS of -$0.09 beat by $0.03. Repay Holdings (RPAY) hasn’t had such a good day. Shares are off more than 10%, although the stock has thus far held above support at 22. The last time RPAY was at that price was the day before Halloween, so we’re still in the stock’s comfort zone (it has been between 21 and 28 since the end of May). Tyler advises a HOLD for Sprout Social (SPT) and a continued BUY for Repay Holdings (RPAY).
Special Bulletin November 10: Arena (ARNA) reported Q3 results yesterday that included mixed results on the ADVISE phase 2b trial evaluating etrasimod in atopic dermatitis (AD). AppFolio (APPF) reported Q3 results yesterday that were roughly in line with expectations. Tyler advises a BUY for Arena (ARNA) and a SELL for AppFolio (APPF).
Special Bulletin November 9: Fiverr (FVRR) has been a major beneficiary of work from home trends in that it has helped businesses and freelancers work together all over the world. SELL A QUARTER, HOLD THE REST.
Monthly Issue November 5: Today’s recommendation, BioLife Solutions (BLFS), designs and manufactures bioproduction tools, hypothermic storage solutions and cryopreservation freeze media for the tissue engineering, cell therapy and gene therapy markets. Products include biopreservation media, automated thawing devices, cloud-connected shipping containers and freezer technologies. In the near-term, look to buy down to support around 26 and up to 35. Following the Q3 earnings report tonight Tyler will update his rating and outlook. Average in!
Cabot Dividend Investor
Monthly Issue November 11: Some long dormant positions and well as the underperforming stocks are reawakening. The most notable change so far is in the health care stocks, AbbVie (ABBV) and Eli Lilly (LLY). ABBV has soared 22% since late October and LLY is 13% higher in the same time frame. In addition the two energy stocks, Enterprise Product Partners (EPD) and Valero Energy (VLO), may be on the cusp of reversing the hideous performance so far this year. The best performing stocks, Innovative Industrial Properties (IIPR) and Qualcomm (QCOM), are continuing to soar ever higher. Due to the valuation and momentum, Tom believes LLY and ABBV are the most attractive stocks to buy right now. This month’s featured stock is Realty Income (O).
Weekly Update November 4: The market doesn’t care about politics. It only cares about money. We may not be out of the woods yet though. We’ll have to see how ugly this gets. But the market likes what it sees so far. In the not-too-distant future, the focus should move to the virus and a vaccine. Good news on that front should enable the market to really take off. Bad news will probably lead to more of the same. There is a likely robust recovery and bull market ahead regardless of who wins. Don’t forget that.
Cabot Marijuana Investor
Update November 11: With all five states that voted on marijuana proposals last week saying “Yes,” the trend toward nationwide legalization is now clearer than ever—and marijuana investors have been acting accordingly. Buying volume has soared, while selling pressure has been minimal. Tim is recommending no changes at this time.
Monthly Issue October 28: Remain heavily invested in a diversified group of the stocks recommended here, but keep an eye on the stocks in case trends change. And remember the importance of position sizing; a major reason that our portfolio has outperformed the index this year is that we’ve overweighted the strongest stocks, while underweighting the weakest. The only substantial change in the portfolio today is a downgrade of Innovative Industrial Properties (IIPR) to Hold.
Cabot Early Opportunities
Special Bulletin November 13: Tyler recommends a Sell for Jamf (JAMF).
Special Bulletin November 11: Tyler has given us a quick update on earnings & ratings for SPT, TXG, DDOG.
Special Bulletin November 10: Tyler has given us a quick update on reducing exposure as pandemic trade winds down for: PTON, CHWY, DT, FIVN
Special Bulletin November 9: Tyler has given us quick earnings notes on: BAND, UPWK, NET, SEDG, PTON, CYRX, NVRO, ALTR.
Monthly Issue October 21: Given that we’re entering the busy part of earnings season, the election is just under two weeks away, stimulus is being debated and the pandemic is anything but contained there are a lot of big factors that could drive the market materially higher or lower in the coming month. That doesn’t mean we can’t do any buying. As always, continue to average into the stocks that are most attractive to you and which you think you’ll have the best chance at holding through the inevitable ups and downs. Overall, Tyler would say this is a good time to keep new positions smaller than in the past. Remember, the big money isn’t typically made over a couple days or weeks, but in the sustained uptrends that great stocks enjoy. Our goal is to hitch a ride on those and keep buying on the way up, preferably before they’ve run too far. Today’s Top Pick is Upwork (UPWK), a direct beneficiary of the pandemic-induced rise of freelance work.
Cabot Profit Booster
Weekly Issue November 10: The Stock – Yeti Holdings (YETI) went into a 12-week correction and consolidation, which set up things for the breakout last week after earnings. Today’s action was far from ideal and could be a sign that the stock needs a little time; even so, we think it’s a decent risk/reward around here.Stop — 45. The Covered Call Trade -Buy Yeti Holdings (YETI) Stock at 51.5, Sell to Open December 52.5 Strike Calls (exp. 12/18) for $2, or a Net Price of 49.5 or less.
Cabot Micro-Cap Insider
Special Bulletin November 11: Riviera Resources (RVRA) just announced that it expects to have between $0MM and $30MM ($15MM at the midpoint) available to distribute at some point in 2021. This is down from its previous range of $0MM to $40MM. Rich recommends to Sell Riviera Resources (RVRA).
Monthly Issue November 11: Today, Rich is going full steam ahead and recommending an investment in a company that has successfully executed a turnaround, transitioning from a mainly print focused business to a software/tech-enabled services business. Donnelley Financial Solutions (DFIN) with modest earnings growth and multiple expansions, coupled with significant debt pay down, the stock should hit 40 by 2024, implying almost 200% upside.
Weekly Update November 4: While volatility has picked up recently, history suggests the market will end the year with a strong run. This week, we have no changes to our recommendations. Over the next couple quarters, Rich looks forward to reviewing quarterly results for Liberated Syndication, Dorchester Minerals, Medexus Pharmaceuticals, and U.S. Neurological Holdings.
Cabot Income Advisor
Weekly Update November 11: The market got game-changing news on Monday. Pfizer (PFE) along with German biotech company BioNTech announced highly encouraging results for a COVID-19 vaccine. Final FDA approval could be just weeks away. And large scale distribution could begin before the end of the year. On the other side of this pandemic, there will likely be an absolutely booming economy, low interest rates and a friendly Fed. The previously long overdue recession and bear market is over with.
Monthly Issue October 28: Several portfolio positions on which covered calls were written exceeded the strike price on options expiration and were likely called away. These stocks include IIPR, QCOM, USB, SBUX and BIP. This happens in an up market. You were rewarded for your troubles will a high income return from capital appreciation as well as the call premium and dividends. Tom’s featured stock this month is: B&G Foods, Inc. (BGS).
Cabot Turnaround Letter
Weekly Update November 13: This week only four companies reported earnings: Berkshire Hathaway (BRK.A), Peabody Energy (BTU), Adient (ADNT), and Toshiba (TOSYY). Bruce moved Barrick Gold (GOLD), Peabody Energy (BTU), and Weyerhaeuser (WY) to Sell earlier this week. The podcast will return next Friday, November 20, 2020 as your chief analyst is traveling this week.
Special Bulletin November 9: We are moving Peabody Energy (BTU) to Sell. The company reported a third quarter loss from continuing operations of $(0.66)/share, much better than consensus estimates of a $(0.92)/share loss. We are also moving Weyerhaueser (WY) to Sell. We discussed in our recent earnings note that the company is highly dependent upon the continued surge in lumber prices to support its profits, as nearly all other segments have shown minimal improvements over the past few years.
Special Bulletin November 9: We are moving Barrick Gold (GOLD) to Sell, as we believe the company’s turnaround is well underway, widely-known and increasingly factored into the share price.
Wall Street’s Best Investments
Daily Alert November 13: The Procter & Gamble Company (PG) (HAS) DRIP Investor
Daily Alert November 12: First Midwest Bancorp, Inc. (FMBIO) Income Securities Investor
Daily Alert November 11: Hasbro, Inc. (HAS) The Prudent Speculator
Daily Alert November 10: International Business Machines Corporation (IBM) Sound Advice
Daily Alert November 9: Masco Corporation (MAS) Directinvesting.com
Monthly Issue October 15: Market volatility has eased a bit this past month, with the Dow Jones Industrial Average gaining almost 1,000 points. The service industry, according to ISM, improved, and the unemployment rate dropped to 7.9% for September. As you’ll see in our Advisor Sentiment Barometer and Market Views, sentiment remains about the same. It seems investors are awaiting the election results before they make any big moves. Nonetheless, our contributors have been very busy selecting ideas that look interesting—no matter how the election turns out. Nancy begins this issue with our Spotlight Stock, Celanese Corporation (CE), a specialty chemical company that is growing its global market share. In Nancy’s Feature article, she explores the catalysts that are driving industry growth, as well as the unique properties that should keep our Spotlight Stock in an industry-leading position.
Ask the Experts
Cabot Options Trader
Question: You asked us to tell you of our successes. Well, my story is one of beginner’s luck!As you know, I have been following the Small-Cap and Early Opportunities for two years, which earned me the money to expand to PrimePro in order to get the Options Trader. As I didn’t have enough cash to keep buying Tyler’s recommendations, I thought of my newfound skill, learned from you.Last week I bought options for UPWK. At first I was dismayed. Within seconds, I had a 25% loss. (Is this because of the huge difference between bid and ask?) Then, to exacerbate the situation, the stock went down... But, earnings came out, the options TRIPPLED (!) and I sold half, as you have taught me.Questions:Should one avoid expensive long-term options with a big difference in bid and ask even though there might be a good outcome?How does one decide whether to buy an in-the-money or an out-of-the-money option?Is there a simple book you can recommend about options trading?As SNAP and UBER were among the first options I have ever bought, naturally, I’m hooked.I thank you for introducing me to a new and exciting passion!
Jacob: That is so great about your UPWK trade, as well as SNAP and UBER. So this is what I would say about the bid/ask etc. ... An illiquid stock like UPWK, yes the big/ask is going to be wide. Its unfortunate that this is the case. That being said, if you like a stock, and you think its going higher, then just go with it. More liquid stocks like SNAP and UBER the bid/ask will be much tighter, and that is why I am able to recommend these stocks to Cabot Options Trader. In terms of in-the-money vs. at-the-money, there is no sure-fire answer. If you REALLY like a stock then you should buy “in” options as they will move faster with the stock. However, they are more expensive. “At” options are less expensive and move fairly quickly with the stock, just not as fast. In general, I buy at-the-money options as it allows me to buy more, and have better leverage. Unfortunately I have never found a book that I love about options trading. So, feel free to use me as your options trading mentor.
Cabot Growth Investor
Question: Have you ever used or thought of using a stock’s price percentage above the 200 dma as an overbought indicator? What is your favorite oversold indicator?
Mike: We do look at that, but like everything, context is key – many times a stock can get very extended early in its run, have a pullback or two, and then motor even higher – to us, we use it but only after a stock has been running for a few months type of thing. It does have value but I would caution against using it as a single measure of “overbought-ness.” I don’t really use any oversold indicator, but I do sometimes like stochastics if you’re talking about a stock heading up – it basically coincides with a 2-3 week correction toward support. But really I tend to just focus mostly on price/volume
Cabot Top Ten Trader
Question: I brought GH on your advice and sold a half position as you entered and exited the trade pretty quickly. I tend to ease out of a position instead of selling everything at once. The stock has performed well since you sold. It is worth holding on to or sell into strength during this rotation? When you move to cash do you just recommend straight cash funds or going to some kind of short duration bond fund while waiting to redeploy?
Mike: GH – not really on the top of my leader board, but it’s acting well enough. If we owned it, we’d probably hold on, but with a stop in the 105 area (certainly above your cost anyway). I would just say it looks OK, not amazing, but we’ll see how it goes. As for cash – just a money market fund. We’re not looking to get an extra 10 basis points in the portfolio by purchasing some bond fund that could go down anyway! We want the liquidity. But feel free to try out whatever, just realize you’re not getting much even if you take the risk of owning a bond fund short-term.
Quarterly Cabot Analyst Meeting
The recording of the Cabot Prime Members Meeting with the Analysts from October 21, 2020 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.
Stock Recommendations Tracker
The table below lists all of the stocks held in any Cabot portfolio.
Updated or revised recommendations from the past week are in purple text.
Stocks added to a portfolio are highlighted in green text.
Closed stock positions in the past week are highlighted in red text.
| Stock | Cabot Small-Cap Confidential | Cabot Global Stocks Explorer | Cabot Growth Investor | Cabot Marijuana Investor | Cabot Stock of the Week | Cabot Undervalued Stocks Advisor | Cabot Dividend Investor |
|---|---|---|---|---|---|---|---|
| ABBV | Buy | ||||||
| ACCD | Buy 1/2 | ||||||
| AEM | Buy | ||||||
| APPF | Sell | ||||||
| APT.AX | Buy 1/2 | ||||||
| ARE | Hold | ||||||
| ARNA | Buy | ||||||
| AVGO | Hold | ||||||
| AVLR | Buy | ||||||
| AZEK | Hold | ||||||
| BABA | Hold | ||||||
| BGS | Buy | Buy | |||||
| BIP | Buy 2/3 | ||||||
| BLFS | Buy | ||||||
| BMY | Buy | ||||||
| BSCL | Buy 1/2 | ||||||
| CCI | Hold 1/2 | ||||||
| CDLX | Hold | ||||||
| CGC | See Advisory | ||||||
| COLM | Buy | Buy | |||||
| CRLBF | See Advisory | ||||||
| CRNC | Buy | ||||||
| CURLF | See Advisory | ||||||
| DDOG | Sell | Sold | |||||
| DLR | Hold | Buy | |||||
| DOW | Hold | ||||||
| EPD | Hold | ||||||
| EQH | Buy | ||||||
| EVBG | Buy | ||||||
| EVER | Sold | ||||||
| FIVE | Buy | ||||||
| FVRR | Sell 1/4 | ||||||
| GM | Buy | Buy | |||||
| GRWG | See Advisory | ||||||
| GSHD | Hold 3/4 | ||||||
| GTBIF | See Advisory | ||||||
| HTHT | Hold | ||||||
| IIPR | See Advisory | Hold 2/3 | |||||
| INSP | Hold 3/4 | ||||||
| JUSHF | See Advisory | Hold 2/3 | |||||
| KO | Buy | ||||||
| KPTI | Buy | ||||||
| LGIQ | Buy 1/2 | ||||||
| LLY | Buy | Buy | |||||
| MKSI | Sell | ||||||
| MO | Buy | ||||||
| MPC | Hold | ||||||
| NEE | Hold | Hold 1/2 | |||||
| NET | Hold 1/2 | ||||||
| NUAN | Buy | ||||||
| NVCR | Buy | Buy 1/2 | Buy | ||||
| O | Buy | ||||||
| PGX | Hold 1/2 | ||||||
| PINS | Sell 1/3 | Buy | |||||
| PLMR | Buy | ||||||
| PWR | Sold | ||||||
| QCOM | Buy | Hold 2/3 | |||||
| QTWO | Buy | ||||||
| REMX | Sell | ||||||
| RGEN | Buy | ||||||
| ROKU | Buy 1/2 | ||||||
| RPAY | Buy | ||||||
| SE | Hold 1/2 | Hold | |||||
| SOLO | Buy 1/2 | ||||||
| SPCE | Buy | Buy | |||||
| SPT | Buy | ||||||
| SSO | Buy | ||||||
| STAG | Hold 1/2 | ||||||
| TAP | Buy | Buy | |||||
| TCNNF | See Advisory | Buy | |||||
| TMX | Buy | ||||||
| TOT | Sell | ||||||
| TPB | See Advisory | ||||||
| TRSSF | See Advisory | ||||||
| TSLA | Hold | ||||||
| TSM | Buy 1/2 | Buy | |||||
| TSN | Buy | ||||||
| TWLO | Hold | ||||||
| UEIC | Hold | ||||||
| VIAC | Buy | ||||||
| VIPS | Buy 1/2 | ||||||
| VLO | Hold 1/2 | ||||||
| VOYA | Sell | ||||||
| VZ | Buy | ||||||
| XEL | Hold 2/3 | ||||||
| ZM | Hold |